Cargando…

Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival

BACKGROUND: The prognosis of patients with gastrointestinal stromal tumors (GISTs) is generally evaluated at the time of diagnosis but does not reflect the survival dynamics of patients in the future. Therefore, the purpose of this article was to evaluate the conditional survival (CS) of Chinese pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shao-jun, Zhang, Si-yu, Dong, Ling-yi, Lin, Guo-sheng, Zhou, Yong-jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559392/
https://www.ncbi.nlm.nih.gov/pubmed/34724907
http://dx.doi.org/10.1186/s12885-021-08828-y
_version_ 1784592750848507904
author Xu, Shao-jun
Zhang, Si-yu
Dong, Ling-yi
Lin, Guo-sheng
Zhou, Yong-jian
author_facet Xu, Shao-jun
Zhang, Si-yu
Dong, Ling-yi
Lin, Guo-sheng
Zhou, Yong-jian
author_sort Xu, Shao-jun
collection PubMed
description BACKGROUND: The prognosis of patients with gastrointestinal stromal tumors (GISTs) is generally evaluated at the time of diagnosis but does not reflect the survival dynamics of patients in the future. Therefore, the purpose of this article was to evaluate the conditional survival (CS) of Chinese patients with GISTs after radical resection. METHODS: This retrospective study included 451 patients who underwent radical surgery for GISTs. A Cox proportional hazard model was used to evaluate the prognostic factors of disease-free survival (DFS). The 3-year conditional DFS (CDFS(3)) of patients who survived for x years was expressed as CDFS(3=)DFS((x + 3))/DFS((x)). RESULTS: The traditional 3-year DFS rate decreased gradually from 94.0% at 3 years to 77.3% at 7 years, while the CDFS(3) rate increased from 94.0 to 95.2% over the survival time of the patients. In addition, classic clinicopathological prognostic factors had different effects on CDFS(3,) with changes observed in survival time, but these effects were only slight or moderate (|d|<0.5). Although multivariate analysis showed that age, sex, mitotic index and tumor rupture were independent risk factors for DFS at baseline, all adverse prognostic factors, except for the mitotic index, lost their predictive significance at 5 years after operation. When the Modified NIH criteria were included, the risk staging was found to be an independent risk factor for recurrence or death. Time-dependent Cox regression analysis showed that the modified NIH criteria independently affected the recurrence or death of GIST patients within 2 years after operation. CONCLUSION: CS provides detailed dynamic survival information about Chinese patients with primary resected GISTs. The mitotic index is of great clinical significance for the monitoring and follow-up of patient populations with a high risk of tumor recurrence or death until 5 years after surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08828-y.
format Online
Article
Text
id pubmed-8559392
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85593922021-11-03 Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival Xu, Shao-jun Zhang, Si-yu Dong, Ling-yi Lin, Guo-sheng Zhou, Yong-jian BMC Cancer Research BACKGROUND: The prognosis of patients with gastrointestinal stromal tumors (GISTs) is generally evaluated at the time of diagnosis but does not reflect the survival dynamics of patients in the future. Therefore, the purpose of this article was to evaluate the conditional survival (CS) of Chinese patients with GISTs after radical resection. METHODS: This retrospective study included 451 patients who underwent radical surgery for GISTs. A Cox proportional hazard model was used to evaluate the prognostic factors of disease-free survival (DFS). The 3-year conditional DFS (CDFS(3)) of patients who survived for x years was expressed as CDFS(3=)DFS((x + 3))/DFS((x)). RESULTS: The traditional 3-year DFS rate decreased gradually from 94.0% at 3 years to 77.3% at 7 years, while the CDFS(3) rate increased from 94.0 to 95.2% over the survival time of the patients. In addition, classic clinicopathological prognostic factors had different effects on CDFS(3,) with changes observed in survival time, but these effects were only slight or moderate (|d|<0.5). Although multivariate analysis showed that age, sex, mitotic index and tumor rupture were independent risk factors for DFS at baseline, all adverse prognostic factors, except for the mitotic index, lost their predictive significance at 5 years after operation. When the Modified NIH criteria were included, the risk staging was found to be an independent risk factor for recurrence or death. Time-dependent Cox regression analysis showed that the modified NIH criteria independently affected the recurrence or death of GIST patients within 2 years after operation. CONCLUSION: CS provides detailed dynamic survival information about Chinese patients with primary resected GISTs. The mitotic index is of great clinical significance for the monitoring and follow-up of patient populations with a high risk of tumor recurrence or death until 5 years after surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08828-y. BioMed Central 2021-11-01 /pmc/articles/PMC8559392/ /pubmed/34724907 http://dx.doi.org/10.1186/s12885-021-08828-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Shao-jun
Zhang, Si-yu
Dong, Ling-yi
Lin, Guo-sheng
Zhou, Yong-jian
Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival
title Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival
title_full Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival
title_fullStr Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival
title_full_unstemmed Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival
title_short Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival
title_sort dynamic survival analysis of gastrointestinal stromal tumors (gists): a 10-year follow-up based on conditional survival
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559392/
https://www.ncbi.nlm.nih.gov/pubmed/34724907
http://dx.doi.org/10.1186/s12885-021-08828-y
work_keys_str_mv AT xushaojun dynamicsurvivalanalysisofgastrointestinalstromaltumorsgistsa10yearfollowupbasedonconditionalsurvival
AT zhangsiyu dynamicsurvivalanalysisofgastrointestinalstromaltumorsgistsa10yearfollowupbasedonconditionalsurvival
AT donglingyi dynamicsurvivalanalysisofgastrointestinalstromaltumorsgistsa10yearfollowupbasedonconditionalsurvival
AT linguosheng dynamicsurvivalanalysisofgastrointestinalstromaltumorsgistsa10yearfollowupbasedonconditionalsurvival
AT zhouyongjian dynamicsurvivalanalysisofgastrointestinalstromaltumorsgistsa10yearfollowupbasedonconditionalsurvival